Chen Award Recipients
Chen Award for Distinguished Academic Achievement in Human Genetic and Genomic Research (2011)
Yang Huanming, China
Beijing Genomics Institute (BGI)
Dr. Yang received his Ph.D. from University of Copenhagen, Denmark, in 1988, and obtained his postdoctoral trainings in France and USA. As one of the co-founders of BGI (formerly Beijing Genomics Institute), he and his collaborators have made a significant contribution to the HGP and HapMap projects, as well as to sequencing and analysing genomes of rice, cucumber, chicken, silkworm, giant panda, ant, maize, soybean, and many microorganisms since 1999. BGI, together with its collaborators, has published the first Asian’s genome, human pan-genome, human ancient genome, and human gut metagenomes by means of new-generation sequencing technology and innovative bioinformatic tools recently in Science, Nature and other internationally prestigious journals. BGI now has become one of the most influential genomics centers in the world and a major contributor to the International 1000 Genomes Project.
Dr. Yang has received many awards and honors, including Research Leader of the Year by Scientific American in 2002 and Award in Biology by the Third World Academy of Sciences (TWAS) in 2006. He was elected as a foreign member of EMBO in 2006, an academician of Chinese Academy of Sciences in 2007, a fellow of TWAS in 2008, a foreign academician of Indian Academy of Sciences in 2009.
Chen New Investigator Award (2011)
Liu Jianjun, Singapore
Genomic Institute of Singapore
Dr Liu's primary interest of research is to understand the relationship between genetic variation and disease phenotype, particularly complex diseases, on a population scale. Using both hypothesis-driven investigation and genome-wide search, Dr Liu's group is working towards identifying genetic variants that contribute to individuals' predisposition to, or protection from, common diseases and further understand their interaction with environmental and/or lifestyle risk factors to influence disease development. Beyond the identification of genetic risk factors, Dr Liu is also interested in understanding the biological mechanisms that underlie genetic risk factors by pinpointing causal variants through fine-mapping analysis and characterizing the functional impact of causal variants using in-vitro and in-vivo model systems. Because the extent and distribution of disease predisposing genetic variation in the human species today is the result of a long and complicated evolutionary, migratory, and demographic history, Dr Liu is also investigating the general processes affecting genetic variation in modern human populations.